<ѻýҕl>High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOLѻýҕl> Patients report better urinary and bowel function outcomes Oct 24, 2022
<ѻýҕl>Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicityѻýҕl> No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease Nov 02, 2021
<ѻýҕl>Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancerѻýҕl> No deaths, progression with RT after early termination because of deaths in surgery arm Oct 29, 2021
<ѻýҕl>Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancerѻýҕl> No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
<ѻýҕl>Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancerѻýҕl> Prolonged adjuvant ADT also improved survival Oct 27, 2021
<ѻýҕl>Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancerѻýҕl> Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients Oct 27, 2021
<ѻýҕl>Gentler Adjuvant RT Could Be Viable for Some HPV-Positive Oral Cancersѻýҕl> Those with extranodal extension didn't fare as well Oct 27, 2021
<ѻýҕl>Gene Test Finds Gradations in High-Risk Prostate Cancerѻýҕl> Study of untreated cancers prognostic for metastasis, cancer mortality, overall survival Oct 26, 2021
<ѻýҕl>No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancerѻýҕl> Women with medially or centrally located tumors may be candidates, however, says researcher Oct 26, 2021
<ѻýҕl>Potential New Standard for Post-Prostatectomy Radiotherapyѻýҕl> Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
<ѻýҕl>Targeted RT Boosts PFS in Oligoprogressive Lung Cancerѻýҕl> Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer Oct 25, 2021
<ѻýҕl>More Evidence for Safety of Accelerated Radiation in Early Breast Cancerѻýҕl> Studies show low toxicity with few recurrences Oct 25, 2021
<ѻýҕl>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapseѻýҕl> Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
<ѻýҕl>High-Dose SBRT More Effective for Painful Spine Metastasesѻýҕl> Roughly one-third of patients had a complete pain response at 3 and 6 months Oct 26, 2020
<ѻýҕl>ASTRO Unveils First RT Guideline for Pancreatic Cancerѻýҕl> Radiation's role in pancreatic cancer is "controversial," says guideline author Sep 23, 2019
<ѻýҕl>Tx Deintensification Wins in Head and Neck Cancer, But ...ѻýҕl> Only against another less-intensive approach in HPV-positive disease Sep 18, 2019
<ѻýҕl>Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLCѻýҕl> Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
<ѻýҕl>Consider PSA Before Adding ADT to Salvage Radiationѻýҕl> Men with levels below 0.6 ng/mL show no benefit, at risk of other-cause mortality Sep 16, 2019
<ѻýҕl>Hippocampus-Sparing Radiation a New Option in Brain Mets Patientsѻýҕl> Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
<ѻýҕl>Black Race Not Associated with Worse Prostate Ca Outcomesѻýҕl> Results contrast with past population registry data Oct 24, 2018
<ѻýҕl>SABR Equally Effective in RCC Patients With One or Both Kidneysѻýҕl> Minimal side effects reported with high-dose treatment Oct 23, 2018
<ѻýҕl>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Caѻýҕl> Cetuximab resulted in more patient deaths across U.S., German studies Oct 23, 2018
<ѻýҕl>Liquid Biopsy Rules Out Relapse in HPV-Positive Oral Caѻýҕl> Test had 100% negative predictive value Oct 23, 2018
<ѻýҕl>Nearly 90% Free of Prostate Ca Progression With ADT, Pelvic Node RTѻýҕl> Data also showed trend toward reduction in distant metastases Oct 22, 2018
<ѻýҕl>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Metsѻýҕl> If new drug produced such a response it would make "millions," said expert Oct 22, 2018
<ѻýҕl>No Increase in Late Effects With Weekly RT in Breast Caѻýҕl> 10-year data show low rate of late-onset effects with 28.5 Gy regimen Oct 21, 2018
<ѻýҕl>RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Caѻýҕl> Highest benefit seen in patients who also used tamoxifen Oct 21, 2018
<ѻýҕl>SBRT Doubles 5-Year Survival in Oligometastatic Cancersѻýҕl> Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018